Reuters logo
5 个月前
BRIEF-Ocular Therapeutix Q4 loss per share $0.52
2017年3月10日 / 下午12点49分 / 5 个月前

BRIEF-Ocular Therapeutix Q4 loss per share $0.52

1 分钟阅读

March 10 (Reuters) - Ocular Therapeutix Inc:

* Ocular Therapeutix(tm) reports fourth quarter and full year 2016 financial results

* Q4 loss per share $0.52

* Q4 earnings per share view $-0.45 -- Thomson Reuters I/B/E/S

* Qtrly total revenue $511,000 versus $436,000

* Ocular Therapeutix Inc - as of december 31, 2016, cash, cash equivalents and marketable securities totaled $68.1 million

* Will need to obtain additional capital to support planned commercial launch of dextenza, subject to fda approval Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below